Donor Government Funding for Family Planning in 2020
In 2020, donor government funding for family planning activities totaled US$1.40 billion, a decline of more than US$100 million compared to the 2019 amount (US$1.52 billion).
Global Health Policy
Refine Results
- view as grid
- view as list
The U.S. Congress and Global Health: A Primer
This primer provides an overview of congressional engagement in global health. It examines the structure of Congress and its role and key activities in global health. It then illustrates these by examining two global health examples: the creation and evolution of PEPFAR and the 2014/2015 Ebola outbreak in West Africa.
The U.S. Government and International Family Planning & Reproductive Health Efforts
This fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
KFF COVID-19 Vaccine Monitor: Views On The U.S. Role In Global Vaccine Distribution
This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public’s views.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
This fact sheet looks at the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.
As PEPFAR Nears its Two-Decade Mark, New Analysis Finds That Mortality Declined Substantially in PEPFAR Countries Over the Course of the Program
A new KFF analysis finds the President’s Emergency Plan for AIDS Relief (PEPFAR) program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003. The new analysis takes a closer look at PEPFAR’s health impact by assessing the all-cause mortality rate in 90 PEPFAR…
Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries
As the PEPFAR program approaches its two-decade mark and begins the process of developing the next five-year strategy, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.
Tracking U.S. COVID-19 Vaccine Donations
This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.
Tracking Global COVID-19 Vaccine Equity: An Update
This updated analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries in Africa are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.
Key Issues and Questions for PEPFAR’s Future
This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.